Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.
暂无分享，去创建一个
M. Ladanyi | R. Somwar | A. Kentsis | M. Gounder | E. de Stanchina | N. Arrighetti | V. Zuco | Y. Kazansky | F. D. Dela Cruz | Ruirui Qu | Daniel Cameron | Phillip Demarest | Helen S. Mueller | Yasumichi Kuwahara | Andrew L Kung | Nadia Zaffaroni